Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 0 | 0 | 0 | 0 | 527 |
| Cost of Goods | N/A | N/A | 0 | N/A | 479 |
| Gross Profit | N/A | N/A | 0 | N/A | 48 |
| Operating Expenses | 16,299 | 14,208 | 17,825 | 9,809 | 11,314 |
| Operating Income | -16,299 | -14,208 | -17,825 | -9,809 | -10,787 |
| Interest Expense | 0 | 0 | 0 | 226 | 219 |
| Other Income | 25 | 23 | -767 | -111 | -305 |
| Pre-tax Income | -16,274 | -14,185 | -18,592 | -10,146 | -11,311 |
| Income Tax | N/A | 0 | 182 | 35 | 20 |
| Net Income Continuous | -16,274 | -14,185 | -18,774 | -10,181 | -11,331 |
| Net Income | $-16,274 | $-14,185 | $-18,774 | $-10,181 | $-11,331 |
| EPS Basic Total Ops | -0.40 | -0.35 | 4.38 | -0.36 | -4.41 |
| EPS Basic Continuous Ops | -0.40 | -0.35 | 3.18 | -0.34 | -3.58 |
| EPS Diluted Total Ops | -0.40 | -0.35 | 4.38 | -0.36 | -4.41 |
| EPS Diluted Continuous Ops | -0.40 | -0.35 | 3.18 | -0.34 | -3.58 |
| EBITDA(a) | $-16,293 | $-14,203 | $-17,738 | $-9,686 | $-10,595 |